Word

Status

Dead

Status Code

709

Status Date

Friday, December 30, 2022

Serial Number

79168971

Registration Number

4975416

Registration Date

Tuesday, June 14, 2016

Mark Type

2000

Filing Date

Wednesday, December 17, 2014

Published for Opposition

Tuesday, March 29, 2016

Cancellation Date

Friday, December 30, 2022

Trademark Owner History

Circassia Limited - Original Registrant

Classifications

5 Pharmaceutical and veterinary preparations for the testing, diagnosis, prevention or treatment of drug dependency, substance addiction, poisoning, overdose, envenomation, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders

42 Scientific research for medical purposes in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; medical and pharmacological research services in the fields of allergies, drug dependency, substance addiction, autoimmune disease, poisoning, overdose, envenomation, transplant rejection, immunodeficiency disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, polyposis, sinusitis, non-allergic rhinitis, obesity, cognitive disorders and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, gynaecological, oncological, hepatological, ocular, haemostasis, obstetric, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, renal system, urinary tract, otolaryngology, psychiatric, fertility and immune system related diseases and disorders; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the fields of pharmaceutical and clinical trials; conducting clinical trials for others; information, advisory and consultancy services relating to the aforesaid

The mark consists of a miscellaneous design comprising seven diamond shapes with the colour dark purple applied to four of the diamond shapes and the colour light purple applied to three of the diamond shapes.
The colour dark purple applied to four of the diamond shapes and the colour light purple applied to three of the diamond shapes, as shown above.
The color(s) dark purple and light purple is/are claimed as a feature of the mark.

Trademark Events

Oct 9, 2023

Total Invalidation Processed By The Ib

Sep 16, 2023

Total Invalidation Of Reg Ext Protection Sent To Ib

Sep 16, 2023

Invalidation Processed

Aug 30, 2023

Total Invalidation Of Reg Ext Protection Created

Dec 30, 2022

Cancelled Section 71

Dec 4, 2021

New Representative At Ib Received

Jun 14, 2021

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Oct 25, 2019

New Representative At Ib Received

Oct 13, 2016

Final Decision Transaction Processed By Ib

Sep 19, 2016

Final Disposition Notice Sent To Ib

Sep 19, 2016

Final Disposition Processed

Sep 14, 2016

Final Disposition Notice Created, To Be Sent To Ib

Jun 14, 2016

Registered-Principal Register

Mar 29, 2016

Official Gazette Publication Confirmation E-Mailed

Mar 29, 2016

Published For Opposition

Mar 25, 2016

Notification Processed By Ib

Mar 9, 2016

Notification Of Possible Opposition Sent To Ib

Mar 9, 2016

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Mar 9, 2016

Notification Of Notice Of Publication E-Mailed

Feb 23, 2016

Approved For Pub - Principal Register

Feb 4, 2016

Teas/Email Correspondence Entered

Feb 4, 2016

Correspondence Received In Law Office

Feb 4, 2016

Teas Response To Office Action Received

Aug 22, 2015

Refusal Processed By Ib

Aug 4, 2015

Non-Final Action Mailed - Refusal Sent To Ib

Aug 4, 2015

Refusal Processed By Mpu

Aug 4, 2015

Non-Final Action (Ib Refusal) Prepared For Review

Aug 3, 2015

Non-Final Action Written

Jul 31, 2015

Application Filing Receipt Mailed

Jul 27, 2015

Assigned To Examiner

Jul 27, 2015

New Application Office Supplied Data Entered

Jul 22, 2015

Limitation From Original Application Entered

Jul 16, 2015

Sn Assigned For Sect 66a Appl From Ib